Here's the Dip -- Will the Buyers Bite?<br />By Rev Shark<br />RealMoney.com Contributor<br />4/19/2010 8:44 AM EDT<br /><br /> The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.<br /> -- William Arthur Ward<br /><br />The selloff triggered by fraud charges against Goldman Sachs (GS) is continuing this morning as overseas markets react and rumors swirl about action against other banks. Adding to the problem is a 4.8% drop of Chinese shares in Shanghai, the biggest loss in eight months, as local governments take steps to crack down on real estate speculation. China stocks have had cooling momentum for a couple of weeks now and have been signaling some potentially bad news.<br /><br />So is the market undergoing a negative change in character, or is this just another hiccup that will be quickly forgotten as the dip-buyers jump in and drive us back to highs? Betting against "V"-shaped recoveries in this market has been a losing game for over a year now -- will it be different this time?<br /><br />Many market players, including me, thought that the dip back in January was going to be different, but we ended up with an even stronger bounce than we had seen during the 2009 run. "V"-shaped recoveries to new highs are not considered to be typical market action, but they have been the norm in this market for quite some time.<br /><br />After just a one-day pullback, it is premature to talk about "V"-shaped bounces, but the issue here is the tenacity of the dip-buyers. The dip-buying approach has worked extremely well for a very long time; the only drawback to the approach has been that there haven't been that many pullbacks to jump on.<br /><br />Market players are not going to give up easily on dip-buying until they have been caught leaning the wrong way. So far they have only be rewarded, so I would not be at all surprised to see them jump in on this Monday-morning weakness, especially when it is widely known that Mondays have been the best-performing day of the week by far.<br /><br />The other positive the bulls have going for them is that the focus is going to stay on earnings for the next couple of weeks. Probably the most important call of the earnings season is going to be Apple (AAPL) on Tuesday night. Until that is out of the way, the bears are probably going to be a little hesitant to press their bets. We haven't had too much of a "sell the news" reaction to good earnings news so far, but conditions are still good for it to occur.<br /><br />The biggest negative this market faces right now it that after the run over the last two months, we are still very technically extended and don't have much support. We went straight up on light volume most of the way, and that just doesn't create much support. The best support on the charts is 1150 on the S&P 500 -- the January highs. That is a long way down, and given the dip-buying inclination of traders we are not likely to get there very quickly.<br /><br />Obviously with the selling pressure we are seeing now, we need to take some defensive action to make sure we don't let losses get out of hand. Even if you are looking for a quick recovery in this market, it is extremely important to stay disciplined and take stops and lock in gains in accordance with your trading plan.<br /><br />The market has yet to undergo a major change in character, and earnings season may delay any significant downside, but we need to increase our vigilance and defensiveness. Nothing is more important than protecting your capital, and if we start to slip we need to move quickly to do so. <br />-----------------------------<br />Briefing.com<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: IDSA +4.8%, HAS +2.6% (light volume), PHG +1.0%, ACI +0.8%.<br /><br />M&A news: CRN +29.9% (The GEO Group to buy Cornell Companies in $685 mln deal; transaction implies GEO to pay premium of 35% at $24.96 per share, based on Friday's closing prices).<br /><br />Other news: EPCT +9.4% (announced that the commercial launch of Ceplene), YMI +4.4% (announces pivotal preclinical efficacy data for the JAK1/2 inhibitor CYT387 published in Blood, the Journal of the American Society of Hematology), TASR +1.7% (receives order for 250 TASER X26 units), LDK +1.2% (reaches milestone of 2.0 gigawats annualized capacity at its wafer plant), RSH +0.8% (RadioShack sale talk heats up - NY Post).<br /><br />Analyst comments: WBCO +3.5% (upgraded to Outperform from Sector Perform at RBC Capital), S +2.2% (upgraded to Outperform from Market Perform at Wells Fargo), FST +1.5% (upgraded to Buy from Neutral at Goldman- added to Conviction Buy list).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: SPF -8.3%, MMR -5.5%, OKSB -3.4%, LLY -2.4%, HAL -1.1%.<br /><br />Select financial related names showing weakness: BPOP -3.4%, NBG -3.0%, UBS -2.7% (SEC probes other soured deals - WSJ), HBC -2.6%, BCS -2.5%, ING -2.5%, BBVA -2.3%, ALL -2.2%, PUK -1.7% (Prudential dismisses defection fears - FT), STD -1.7%, BAC -1.5%, AIG -1.4%, CS -1.4%, GS -0.7% (Germany, UK demand Goldman Sachs probe - Reuters; removed from FBR Top Picks list).<br /><br />Select metals/mining stocks trading lower: SLW -3.0%, IAG -2.4%, BBL -2.3%, BHP -2.3%, RTP -2.1%, GOLD -2.0%, MT -1.5%, ABX -1.2%, GLD -0.3%.<br /><br />Select oil/gas related names showing weakness as crude oil extends its sell off from Friday's session: STO -3.0%, BP -2.3%, TOT -1.8%, RDS.A -1.7%, PBR -1.6%, E -1.6%, COP -1.4%, REP -1.4%.<br /><br />Select airlines trading lower with continued flight disruptions from ash: CAL -3.2%, LCC -2.8%, AMR -2.2%, DAL -1.1%, UAUA -1.0%.<br /><br />Other news: RNN -12.0% (pulling back from past three trading day run-up), TNE -9.8% (trading ex dividend), BVX -7.8% (announces $3 mln private placement), ZN -6.9% (discloses letter to shareholders providing investor update; will purchase AME's drilling rig for an initial payment of $7 mln and series of $1 mln additional payments), RYAAY -4.7% (traded lower overseas), XCO -3.7% (filed for a ~64.287 mln share common stock offering by selling shareholders), RCL -3.5% and CCL -3.1% (still checking for anything specific), ABB -2.3% (still checking).<br /><br />Analyst comments: ESE -5.0% (downgraded to Underperform from Sector Perform at RBC Capital Mkts; tgt lowered to $24 from $32 ), PALM -4.1% (Departure & retention actions likely a sign acq not pending - UBS; downgraded to Underperform at Morgan Keegan), SNDK -2.4% (downgraded to Underperform from Sector Perform at Pacific Crest), KG -2.3% (downgraded to Sell from Neutral at Goldman ), CVE -2.1% (downgraded to Market Perform from Outperform at BMO Capital Markets), PT -1.9% (downgraded to Hold from Buy at Citigroup), MRX -1.9% (downgraded to Neutral from Buy at Goldman), LPNT -0.9% (downgraded to Sell from Neutral at Goldman).